Table: Green Peptide -2016/17 group forecast

BrightPath Biotherapeutics Co

12/05/2017 07:00

May 12 (Reuters) - 
              Green Peptide Co., Ltd.      
              CONSOLIDATED EARNINGS ESTIMATES 
  (in billions of yen unless specified)                     
                 Full Year to      Full Year to  
               Mar 31, 2017      Mar 31, 2017    
                  LATEST           PREVIOUS      
                 FORECAST          FORECAST      
  Sales           529 mln           406 mln      
  Operating      loss 1.11         loss 1.31     
  Recurring      loss 1.12         loss 1.31     
  Net            loss 1.11         loss 1.31     
  EPS         loss 32.74 yen    loss 41.14 yen   
  
  NOTE - Green Peptide Co., Ltd..     
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
 ((Tokyo Headline News Desk +813 6441 1812))